CD133+ renal progenitor cells contribute to tumor angiogenesis.
about
Renal Cancer Stem Cells: Characterization and Targeted TherapiesCurrent approaches in identification and isolation of human renal cell carcinoma cancer stem cellsPotential Reparative Role of Resident Adult Renal Stem/Progenitor Cells in Acute Kidney InjuryBiology of renal tumour cancer stem cells applied in medicineTargeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem CellsOct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cellsComparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer CellsEcto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells.Endothelium originated from colorectal cancer stem cells constitute cancer blood vesselsCD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma.Differentiated kidney epithelial cells repair injured proximal tubule.Metastasis-Initiating Cells in Renal Cancer.Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell markerCharacterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities.Endothelial cell differentiation of human breast tumour stem/progenitor cells.Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.High-level expression of stem cell marker CD133 in clear cell renal cell carcinoma with favorable prognosis.Functional significance of CD105-positive cells in papillary renal cell carcinoma.Understanding melanoma stem cellsThe Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis.CD133 antisense suppresses cancer cell growth and increases sensitivity to cisplatin in vitroAnti-Cancer Effect of Ginsenoside F2 against Glioblastoma Multiforme in Xenograft Model in SD RatsCancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisited.Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma.Targeting CD133 antigen in cancer.Targeted therapy for renal cell carcinoma: The next lap.Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted celThe cancer stem cell hypothesis: failures and pitfalls.The role of colorectal cancer stem cells in metastatic disease and therapeutic responseCD133+ cells as a therapeutic target for kidney diseases.CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.Vascular remodeling in cancer.Progress of molecular targeted therapies for advanced renal cell carcinoma.The relationship of cancer stem cells in urological cancers.Progenitor/stem cells in renal regeneration and mass lesions.Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment.Role of ursolic acid chalcone, a synthetic analogue of ursolic acid, in inhibiting the properties of CD133(+) sphere-forming cells in liver stem cells.Profilin 2 promotes migration, invasion, and stemness of HT29 human colorectal cancer stem cells.CD58, a novel surface marker, promotes self-renewal of tumor-initiating cells in colorectal cancer.
P2860
Q26746970-0DDB5B07-65FE-460F-A877-17E504BCE6F8Q26786047-9A0FB490-1253-442C-9A8E-0C6AC0A3F5AAQ26796775-DE721CDE-F256-4E9F-9F7D-BAFB9B5086F2Q27004622-9620F87E-BC58-4FC6-94C0-5A08D6DBA564Q28078154-E068FC5F-8465-4A67-9F51-FAE6A6C86A82Q28473082-E47AA327-FA41-490E-ADFB-D4E5113C5BEFQ28553202-C11B1A24-550F-43C1-B241-C3DD1B52B680Q33761985-2240116F-BEC9-45D7-8DBE-BA47894048AEQ33873312-6590671C-0F2B-4050-80D6-9749B4806336Q33974370-965CE20A-19C4-4480-8ACF-3CCEEED6ED78Q34038540-D3DC233B-DA1E-43FB-BB35-68B606E7E563Q34077268-FC522D33-BD8B-46AD-BD03-95D5BAA0238EQ34203737-7945E5C8-3E38-4466-8198-0812BDDA89CCQ34644926-69C37C40-350A-4B15-9E11-4C6287D05C1FQ34919522-9C81F840-8AD7-44D7-97E5-FFC399067066Q35459525-0F3F1814-0D77-4E68-936C-37595634B07EQ36121660-4094186C-6FFB-4B55-B109-C085117B5F89Q36241043-C547921F-19B1-4548-8480-BE8D9E342BA2Q36292299-CBA04035-0121-40FA-98A6-F441D137062BQ36300487-7DBE9220-0F2F-4C32-BC75-2D3CA9DE0A1CQ36385360-BF341D31-E244-44F3-B400-FD2CDEF0E920Q36861061-68930C9F-9681-470F-B99C-49CA02EF6D6DQ37077230-5ED88C23-32AA-48BA-931A-04EEA877021EQ37144023-6D3978BE-909D-4EFC-8417-26A6460A47ECQ37269232-D7B707BC-F26A-4E5A-AF96-6C665D0AD837Q37521082-DF43BC31-EF8A-4FA0-924B-2786CF465C1EQ37702529-EEA3AEC0-A0C8-42A2-BE22-F125B9F3B78EQ37716584-32D338A2-EAF0-4AFA-80E2-462C0BFD701FQ37816878-B6736087-788F-4810-8055-209499D6FED0Q37841141-BED1A9C1-1B57-4E2B-A533-7B27180FD9BDQ37983119-03DE38BC-3B09-4DAA-A0F5-8F049DB17BE3Q38035206-E278FE57-93E3-454E-AAAC-EA76950F9B21Q38126351-1DEA6BE4-BD45-4F43-87B2-AC8E18F193ECQ38149133-5A97BE4A-D60F-49D3-8D27-C207CC35F3A4Q38202644-EF166E4E-9A52-4F00-B294-4DE9CEBAABD7Q38245544-A80E6C1C-21BC-4264-A4D3-4B445DE32A24Q38844070-7948871E-E22C-4F19-889E-8357CF8F5AC8Q38875128-4EB2A8C3-9249-417C-8A96-F7CC16F7D532Q38876097-0B86A786-8E40-41DF-A7B3-E626A1A9539AQ39004664-AE012D74-2724-4113-A21A-301A2F87DA3B
P2860
CD133+ renal progenitor cells contribute to tumor angiogenesis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
CD133+ renal progenitor cells contribute to tumor angiogenesis.
@ast
CD133+ renal progenitor cells contribute to tumor angiogenesis.
@en
type
label
CD133+ renal progenitor cells contribute to tumor angiogenesis.
@ast
CD133+ renal progenitor cells contribute to tumor angiogenesis.
@en
prefLabel
CD133+ renal progenitor cells contribute to tumor angiogenesis.
@ast
CD133+ renal progenitor cells contribute to tumor angiogenesis.
@en
P2093
P2860
P50
P1476
CD133+ renal progenitor cells contribute to tumor angiogenesis.
@en
P2093
Manuela Efrem Graziano
Stefania Bruno
Ugo Ferrando
P2860
P304
P356
10.2353/AJPATH.2006.060498
P407
P577
2006-12-01T00:00:00Z